Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety

Imtiaz Salim, Jassim Al Suwaidi, Wissam Ghadban, Amar M Salam
  • Expert Opinion on Drug Safety, October 2012, Informa Healthcare
  • DOI: 10.1517/14740338.2013.732569

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1517/14740338.2013.732569

The following have contributed to this page: Dr Jassim Al Suwaidi

In partnership with: